Search

everythinglearnresearchcommunity

for

Search:↓

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Former finasteride users showed higher rates of depression and suicidal thoughts compared to those who never used it.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride can cause sexual problems and depression in young men.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

Hair loss in women linked to higher sexual dysfunction risk.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

Nanoparticle systems make cancer treatment less toxic.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Finasteride reduces movement issues in Parkinson's disease rats.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Laser pubic hair removal boosts self-esteem, body image, and sexual functions in women.

Technology can improve sexual dysfunction in chronic disease patients but faces challenges like cost and accessibility.